Marker: D1Mgh16 |
Symbol: |
D1Mgh16 |
Previously known as: |
R5372a; oxsts4760;
|
RGD ID: |
43175 |
Expected Size: |
143 (bp) |
Position |
Rat Assembly | Chr | Position (strand) | Source | JBrowse |
---|
mRatBN7.2 | 1 | 5,925,874 - 5,926,029 (+) | MAPPER | mRatBN7.2 | Rnor_6.0 | 1 | 5,655,769 - 5,655,923 | NCBI | Rnor6.0 | Rnor_5.0 | 1 | 7,306,799 - 7,306,953 | UniSTS | Rnor5.0 | RGSC_v3.4 | 1 | 6,253,946 - 6,254,099 | RGD | RGSC3.4 | RGSC_v3.4 | 1 | 6,253,947 - 6,254,099 | UniSTS | RGSC3.4 | RGSC_v3.1 | 1 | 6,253,946 - 6,254,099 | RGD | | Celera | 1 | 4,440,932 - 4,441,078 | UniSTS | | RH 3.4 Map | 1 | 106.1 | UniSTS | | RH 3.4 Map | 1 | 106.1 | RGD | | RH 2.0 Map | 1 | 0.0 | RGD | | Cytogenetic Map | 1 | | RGD | |
|
Is Marker For: |
QTLs:
Hcas2
|
QTLs in Region (mRatBN7.2)
1354647 | Despr8 | Despair related QTL 8 | | 0.0000341 | locomotor behavior trait (VT:0001392) | amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) | 1 | 1 | 24744506 | Rat |
2298546 | Neuinf4 | Neuroinflammation QTL 4 | 5.1 | | nervous system integrity trait (VT:0010566) | spinal cord RT1-B protein level (CMO:0002132) | 1 | 1 | 28736750 | Rat |
2313053 | Bss51 | Bone structure and strength QTL 51 | 3.8 | 0.0001 | tibia length (VT:0004357) | tibia length (CMO:0000450) | 1 | 1 | 32356093 | Rat |
2313070 | Bss52 | Bone structure and strength QTL 52 | 4.4 | 0.0001 | body length (VT:0001256) | body length (CMO:0000013) | 1 | 1 | 32356093 | Rat |
2313090 | Bmd69 | Bone mineral density QTL 69 | 4.4 | 0.0001 | tibia mineral mass (VT:1000283) | compact volumetric bone mineral density (CMO:0001730) | 1 | 1 | 32356093 | Rat |
738020 | Pia8 | Pristane induced arthritis QTL 8 | 4.7 | | joint integrity trait (VT:0010548) | joint inflammation composite score (CMO:0000919) | 1 | 1 | 65833076 | Rat |
1578650 | Bmd6 | Bone mineral density QTL 6 | 12.2 | | femur mineral mass (VT:0010011) | total volumetric bone mineral density (CMO:0001728) | 1 | 509108 | 43284926 | Rat |
1578651 | Bmd7 | Bone mineral density QTL 7 | 14.2 | | femur mineral mass (VT:0010011) | compact volumetric bone mineral density (CMO:0001730) | 1 | 509108 | 43284926 | Rat |
1578669 | Bss9 | Bone structure and strength QTL 9 | 6.3 | | femur morphology trait (VT:0000559) | bone trabecular cross-sectional area (CMO:0002311) | 1 | 509108 | 43284926 | Rat |
1554320 | Bmd1 | Bone mineral density QTL 1 | 12.2 | 0.0001 | femur mineral mass (VT:0010011) | volumetric bone mineral density (CMO:0001553) | 1 | 509108 | 86060548 | Rat |
1600360 | Mcs16 | Mammary carcinoma susceptibility QTL 16 | 2.4 | | mammary gland integrity trait (VT:0010552) | mammary tumor number (CMO:0000343) | 1 | 2244390 | 43433040 | Rat |
1300170 | Rf6 | Renal function QTL 6 | 3.14 | | renal blood flow trait (VT:2000006) | absolute change in renal blood flow rate (CMO:0001168) | 1 | 4162807 | 11481482 | Rat |
7421626 | Bp360 | Blood pressure QTL 360 | | 0.001 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 1 | 4393289 | 49393289 | Rat |
631688 | Hcas2 | Hepatocarcinoma susceptibility QTL 2 | 3 | 0.0001 | liver integrity trait (VT:0010547) | liver tumorous lesion number (CMO:0001068) | 1 | 5925874 | 115540829 | Rat |
4889451 | Eae29 | Experimental allergic encephalomyelitis QTL 29 | 5.51 | | nervous system integrity trait (VT:0010566) | experimental autoimmune encephalomyelitis severity score (CMO:0001419) | 1 | 5925877 | 24697545 | Rat |